Reducing infection risk starts with rigorous science — and a clear path to market.
Innovotech Corporation (TSXV: IOT)(OTCQB: IOTCF) has been engaged by FendX Technologies (CSE: FNDX)(OTCQB: FDXTF)(FSE: E8D0) to assess the FDA regulatory pathway for their coated Foley catheter, a technology designed to reduce bacterial growth on one of the most common indwelling medical devices.
Innovotech is proud to bring our regulatory expertise with real potential to improve patient outcomes.
Learn more https://lnkd.in/dwQJVjVQ
